Palisade Bio, Inc. (PALI)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
PALI price, last 12 months
Key stats
- Previous close
- $0.9421
- Open
- $0.9400
- Day range
- $0.9183 – $0.9858
- 52-week range
- $0.8381 – $2.86
- Volume
- 2.7M
- Avg volume (20 days)
- 4M
- Market cap
- $201.0M
Performance
Technicals and fundamentals
About Palisade Bio, Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $201.0M